Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis.
暂无分享,去创建一个
[1] C. Kjellstrand,et al. Exacerbation of diabetic renal failure following intravenous pyelography. , 1977, The American journal of medicine.
[2] M. Hlatky,et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. , 1989, The New England journal of medicine.
[3] E. Bartels,et al. Acute anuria following intravenous pyelography in a patient with myelomatosis. , 2009, Acta medica Scandinavica.
[4] H. Conn,et al. Acute renal failure after intravenous pyelography in plasma cell myeloma. , 1958, Journal of the American Medical Association.
[5] D. Feinfeld,et al. THE RISK OF RADIOCONTRAST NEPHROPATHY IN PATIENTS WITH CIRRHOSIS , 2002, Renal failure.
[6] N. Milman,et al. Renal function after high-dose urography in patients with chronic renal insufficiency. , 1977, Clinical nephrology.
[7] R. Marcén,et al. Renal function impairment caused by intravenous urography. A prospective study. , 1981, Archives of internal medicine.
[8] R. Reznek,et al. Renal function after high dose urography in patients with renal failure. , 1981, The British journal of radiology.
[9] M. Hlatky,et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. , 1989, Annals of internal medicine.
[10] E. Brodwall,et al. Acute renal failure following intravenous pyelography in cases of myelomatosis. , 2009, Acta medica Scandinavica.
[11] N. Milman,et al. High-Dose Urography in Advanced Renal Failure , 1974, Acta radiologica: diagnosis.
[12] F. Lithner,et al. Nephrotoxicity of Contrast Media in Patients with Diabetes Mellitus , 1989, Acta radiologica.
[13] W. Hoy,et al. Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. , 1978, Annals of internal medicine.
[14] J. Cohen,et al. Hospital-acquired renal insufficiency: a prospective study. , 1983, The American journal of medicine.
[15] W. B. Schwartz,et al. Intravenous urography in the patient with renal insufficiency. , 1963, The New England journal of medicine.
[16] M. Tublin,et al. Current concepts in contrast media-induced nephropathy. , 1998, AJR. American journal of roentgenology.
[17] D. O’Connell,et al. Failure to demonstrate contrast nephrotoxicity , 1991, The Medical journal of Australia.
[18] T. Gleeson,et al. Contrast-induced nephropathy. , 2004, AJR. American journal of roentgenology.
[19] J. Kollath,et al. Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients. , 1989, Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband.
[20] F. Lithner,et al. Assessment of possible nephrotoxicity from iohexol in patients with normal and impaired renal function , 1998, Acta radiologica.
[21] W. Berdon,et al. Tamm-Horsfall proteinuria. Its relationship to prolonged nephrogram in infants and children and to renal failure following intravenous urography in adults with multiple myeloma. , 1969, Radiology.
[22] M. Cova,et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial , 1998, European Radiology.
[23] C. Kjellstrand,et al. Intravenous pyelography in nonuremic diabetic patients. , 1979, Nephron.
[24] M. Galanski,et al. Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] F. Barral,et al. Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. , 2003, European journal of internal medicine.
[26] J. Porush,et al. Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. , 1981, Archives of internal medicine.
[27] D. Baim,et al. Current complications of diagnostic and therapeutic cardiac catheterization. , 1988, Journal of the American College of Cardiology.
[28] J. Lemke,et al. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. , 1991, Radiology.
[29] R. E. Fulton,et al. Intravenous urography in renal insufficiency. , 1969, The American journal of roentgenology, radium therapy, and nuclear medicine.
[30] S. Killmann,et al. Fatal acute renal failure following intravenous pyelography in a patient with multiple myeloma. , 2009, Acta medica Scandinavica.
[31] B. Strom,et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. , 1987, The American journal of medicine.
[32] J. H. Kaye,et al. Acute renal failure in diabetic patients after intravenous infusion pyelography. , 1973, Clinical nephrology.
[33] A. Karle,et al. Urography in Renal Failure , 1971, Acta radiologica: diagnosis.
[34] E. Friedman,et al. Low risk of contrast media-induced acute renal failure in nonazotemic type 2 diabetes mellitus. , 1982, Kidney international.
[35] G. Schreiner,et al. Acute renal failure following drip infusion pyelography. , 1978, The American journal of medicine.
[36] R. Giordani,et al. Effects on renal hemodynamics and tubular function of the contrast medium iohexol in renal patients. , 1990, Renal failure.
[37] T. Shafi,et al. Infusion intravenous pyelography and renal function. Effects in patients with chronic renal insufficiency. , 1978, Archives of internal medicine.
[38] J. Jakobsen. Renal experience with Visipagne , 2006, European Radiology.
[39] K. Rootwelt,et al. High Dose Urography in Patients with Renal Failure , 1985, Acta radiologica: diagnosis.
[40] R. Fischbach,et al. Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase-III trial , 2004, European Radiology.
[41] G. Cederbom,et al. Clearances of inulin and para-aminohippurate before and after urography using high dosage of contrast medium in patients with renal insufficiency. , 1968, Scandinavian journal of urology and nephrology.
[42] G. H. Myers,et al. Acute renal failure after excretory urography in multiple myeloma. , 1971, The American journal of roentgenology, radium therapy, and nuclear medicine.
[43] S. Massry,et al. Acute Renal Failure Following Intravenous Use of Radiographic Contrast Dyes in Patients with Diabetes Mellitus , 1977, Diabetes.
[44] R. Hattery,et al. Acute renal failure after excretory urography in diabetic patients. , 1975, Annals of internal medicine.
[45] U. Brunner,et al. [Acute renal failure following intravenous pyelography in multiple myeloma]. , 1960, Swiss medical weekly.
[46] N. Powe,et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. , 1992, Radiology.
[47] W Zidek,et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.
[48] D. Baldwin,et al. Acute renal failure due to radio-contrast agents. , 1976, Nephron.
[49] L. Groop,et al. Iohexol and Metrizoate in Urography of Insulin Dependent Patients , 1986, Acta radiologica: diagnosis.
[50] D. Baumgarten,et al. Are screening serum creatinine levels necessary prior to outpatient CT examinations? , 2000, Radiology.
[51] Renal function following infusion of radiologic contrast material. A prospective controlled study. , 1985, Archives of internal medicine.
[52] R. Katzberg,et al. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. , 1997, Radiology.